NEOSENS

Curated by Signal

AI-based diagnostic platform for early health assessment and sepsis detection

Overview

AI-based diagnostic platform for early health assessment and sepsis detection. The company is developing an AI-based point-of-care diagnostic assistant to provide an accurate sepsis score from a drop of blood. It is focused on addressing the critical challenge of diagnosing neonatal sepsis, a severe medical emergency.

Key facts

Founded: 2022
Headquarters: Lausanne, Switzerland
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

OptaMed
Platform offering practice management software
Health TechnologyFribourg, Switzerland
ODI Pharma
Provider of medical cannabis products for multiple applications
Health TechnologyZug, Switzerland
Yoosana
Online social platform for fitness and diet coaching
Health TechnologyZollikon, Switzerland

About NEOSENS

What does NEOSENS do?

AI-based diagnostic platform for early health assessment and sepsis detection.

Where is NEOSENS headquartered?

NEOSENS is headquartered in Lausanne, Switzerland.

When was NEOSENS founded?

NEOSENS was founded in 2022.

Which sector is NEOSENS in?

NEOSENS operates in Health Technology.

Who are NEOSENS's competitors?

Companies similar to NEOSENS include OptaMed, ODI Pharma, and Yoosana.